UBS Lux Equity Fund Biotech USD vs Franklin Global Quality Dividend

UBS Lux Equity Fund Biotech USD vs Franklin Global Quality Dividend

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. Franklin Global Quality Dividend

  • Security

    Franklin Global Quality Dividend UCITS ETF

  • Fee

    0.45%

  • ISIN

    IE00BF2B0M76

  • Holdings

    20

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Franklin Global Quality Dividend, we have 27 holdings where Broadcom is the largest holding (2.39), followed by AbbVie (2.37) and Qualcomm (2.2).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Franklin Global Quality Dividend.

UBS Lux Equity Fund Biotech USD Franklin Global Quality Dividend
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Broadcom Inc
USA
2.39 %
2. Moderna Inc
9.21 %
2. AbbVie Inc
USA
2.37 %
3. Vertex Pharmaceuticals Inc
8.44 %
3. Qualcomm Inc
USA
2.2 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4. Amgen Inc
USA
2.19 %
5. AbbVie Inc
USA
4.91 %
5. Merck & Co Inc
Germany
2.18 %
6. Gilead Sciences Inc
USA
4.66 %
6. Novartis AG
Switzerland
2.13 %
7. Amgen Inc
USA
4.43 %
7. 3M Co
USA
2.12 %
8. BioNTech SE
4.13 %
8. Royal Bank of Canada
Canada
2.11 %
9. Karuna Therapeutics Inc
3.75 %
9. Commonwealth Bank of Australia
Australia
2.1 %
- 10. Texas Instruments Inc
USA
2.09 %
- 11. Taiwan Semiconductor Manufacturing Company
Taiwan
2.04 %
- 12. Emerson Electric Co
USA
2.03 %
- 13. Johnson & Johnson Inc
USA
2.03 %
- 14. Allianz SE
Germany
2.03 %
- 15. Eaton Corporation Plc
Ireland USA
2 %
- 16. Cisco Systems Inc
USA
1.99 %
- 17. United Parcel Service Inc
USA
1.98 %
- 18. Coca-Cola Company
USA
1.94 %
- 19. Lockheed Martin Corp
USA
1.93 %
- 20. Paychex Inc
USA
1.93 %

The list of fund holdings was last updated on July 25, 2025.